Skip to main content

Table 1 Baseline Characteristics presented as mean ± standard deviation for continuous or N (%) for categorical data

From: Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes

  Diabetes mellitus Control P value
N 94 20  
Age (years) 60.8 ± 11.1 57.2 ± 11.6 0.72
Male gender, n (%) 76 (81) 14 (70) 0.34
Body mass index, kg/m2 28.7 ± 4.3
Duration of diabetes, years 5.1 ± 4.5
HbA1c, mmol/mol 61.6 ± 15.6 37.1 ± 4.6 < 0.0001
Median HbA1c since diagnosis, mmol/mol 63.8 ± 15.2
Maximum HbA1c since diagnosis, mmol/mol 85.0 ± 24.6
Microalbuminuria, n (%) 45 (48)
Systolic BP, mmHga 131.1 ± 15.2 127.8 ± 15.5 0.93
Diastolic BP, mmHga 72.3 ± 9.0 76.9 ± 10.3 0.05
Total cholesterol, mmol/L 4.3 ± 1.1 5.2 ± 0.9 0.003
Smoking 15 (16) 0
Metformin 83 (88) 0
Sulphonylurea 32 (34) 0
Gliptin 10 (11) 0
Other hypoglycaemic 4 (4) 0
Insulin 0 0
ACE inhibitor 0 0
Beta blocker 3 (3) 0
Calcium channel blocker 10 (11) 1 (5) 0.44
Diuretic 4 (4) 0
Statin 66 (70) 3 (15) < 0.0001
Aspirin 16 (17) 2 (10) 0.43
Serum aldosterone, pmol/L 306.3 ± 18.8
High sensitivity C reactive protein, mg/L 3.5 ± 5.5
Ascending aortic distensibility, 10−3 mmHg−1 1.81 ± 1.16 2.78 ± 1.67 0.002
Descending aortic distensibility, 10−3 mmHg−1 2.11 ± 1.05 3.47 ± 1.54 0.0002
Pulse wave velocity, m/s 8.00 ± 2.87 7.58 ± 2.11 0.74
  1. ACE angiotensin converting enzyme, CVD cardiovascular disease
  2. a24 h blood pressure in patients with diabetes mellitus, clinic blood pressure in controls